US Stock MarketDetailed Quotes
MDXH MDxHealth
- 1.870
- -0.010-0.53%
Close Nov 25 16:00 ET
92.56MMarket Cap-1222P/E (TTM)
2.000High1.800Low244.59KVolume1.880Open1.880Pre Close468.03KTurnover0.70%Turnover RatioLossP/E (Static)49.50MShares4.64052wk High5.45P/B65.77MFloat Cap1.55052wk Low--Dividend TTM35.17MShs Float131.700Historical High--Div YieldTTM10.64%Amplitude1.550Historical Low1.913Avg Price1Lot Size
MDxHealth Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -31.84%-5.62M | 23.51%-4.28M | -29.22%-5.52M | 36.99%-21.5M | 24.16%-7.37M | 54.19%-4.26M | 13.18%-5.59M | 50.65%-4.27M | -51.31%-34.12M | -74.09%-9.72M |
| Net income from continuing operations | -33.57%-6.09M | 4.20%-7.42M | 24.24%-6.6M | 27.90%-27.33M | 29.52%-6.31M | 61.77%-4.56M | 15.57%-7.74M | -11.02%-8.72M | -41.20%-37.9M | -23.46%-8.95M |
| Depreciation and amortization | 15.17%2.15M | 1.24%1.8M | 16.14%1.9M | 39.72%6.86M | -22.30%1.58M | 43.79%1.87M | 125.10%1.78M | 107.88%1.64M | 61.69%4.91M | 153.23%2.04M |
| Other non cash items | 30.95%-290K | 273.11%206K | -100.12%-1K | 189.01%421K | 121.51%145K | -319.90%-420K | ---119K | --815K | -45.54%-473K | ---674K |
| Change In working capital | -32.08%-1.75M | 63.54%610K | -153.15%-978K | -35.14%-2.12M | -17.44%-3M | -229.27%-1.33M | -77.84%373K | 207.23%1.84M | -534.72%-1.57M | -974.37%-2.56M |
| -Change in receivables | -61.98%-737K | -201.44%-1.41M | -502.31%-1.39M | 67.14%-1.68M | -880.46%-2.96M | 86.03%-455K | 227.95%1.39M | 172.23%346K | -270.35%-5.12M | 57.10%-302K |
| -Change in inventory | -224.74%-630K | -10.25%-710K | -189.23%-265K | -8.65%-452K | -55.72%89K | 55.81%-194K | -104.44%-644K | 116.79%297K | -200.73%-416K | -55.82%201K |
| -Change in payables and accrued expense | 43.34%-383K | 837.03%2.73M | -43.27%679K | -99.50%20K | 94.67%-131K | -114.32%-676K | -112.01%-370K | 187.12%1.2M | 198.72%3.97M | -22,427.27%-2.46M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -31.84%-5.62M | 23.51%-4.28M | -29.22%-5.52M | 36.99%-21.5M | 24.16%-7.37M | 54.19%-4.26M | 13.18%-5.59M | 50.65%-4.27M | -51.31%-34.12M | -74.09%-9.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 97.04%-13K | 50.82%-776K | 50.08%-618K | 86.46%-3.93M | 78.06%-676K | 98.22%-439K | -266.13%-1.58M | -34.86%-1.24M | -3,181.13%-29.04M | -1,228.02%-3.08M |
| Net PPE purchase and sale | 14.63%-210K | 58.57%-566K | 72.05%-220K | 1.51%-2.75M | 73.87%-348K | 53.76%-246K | -282.63%-1.37M | -38.56%-787K | -211.27%-2.79M | -448.15%-1.33M |
| Net intangibles purchase and sale | --0 | 18.67%-427K | -19.56%-544K | -65.36%-2.27M | 64.11%-660K | -169.00%-632K | -419.80%-525K | -30.00%-455K | ---1.37M | ---1.84M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---25M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 97.04%-13K | 50.82%-776K | 50.08%-618K | 86.46%-3.93M | 78.06%-676K | 98.22%-439K | -266.13%-1.58M | -34.86%-1.24M | -3,181.13%-29.04M | -1,228.02%-3.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,581.41%33.55M | 936.52%11.91M | -104.58%-1.75M | 55.82%32.28M | -1,984.55%-2.29M | -110.09%-2.27M | -78.22%-1.42M | 4,800.49%38.26M | -68.85%20.72M | -100.28%-110K |
| Net issuance payments of debt | -10.98%-1.48M | 2,738.17%13.82M | -25.49%-635K | -114.77%-3.27M | -244.06%-909K | -105.89%-1.33M | -1.35%-524K | 13.50%-506K | 2,193.47%22.13M | 308.25%631K |
| Net common stock issuance | --37.21M | --0 | --0 | --39.6M | --0 | --0 | --0 | --39.6M | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---165K | --29K | ---170K | ---440K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,581.41%33.55M | 936.52%11.91M | -104.58%-1.75M | 55.82%32.28M | -1,984.55%-2.29M | -110.09%-2.27M | -78.22%-1.42M | 4,800.49%38.26M | -68.85%20.72M | -100.28%-110K |
| Net cash flow | ||||||||||
| Beginning cash position | -45.93%21.34M | -69.96%14.49M | 44.36%22.38M | -73.50%15.5M | 19.53%32.71M | -1.38%39.47M | 0.53%48.25M | -73.50%15.5M | 266.69%58.5M | 10.78%27.37M |
| Current changes in cash | 500.83%27.92M | 179.79%6.86M | -124.07%-7.89M | 116.15%6.85M | 13.69%-10.34M | 43.84%-6.97M | -12.03%-8.6M | 415.54%32.76M | -198.55%-42.44M | -135.40%-11.98M |
| Effect of exchange rate changes | -97.12%6K | 95.72%-8K | 80.00%-1K | 104.50%25K | -92.44%9K | 181.89%208K | 37.87%-187K | 95.80%-5K | -6.73%-555K | 291.94%119K |
| End cash Position | 50.61%49.27M | -45.93%21.34M | -69.96%14.49M | 44.36%22.38M | 44.36%22.38M | 19.53%32.71M | -1.38%39.47M | 0.53%48.25M | -73.50%15.5M | -73.50%15.5M |
| Free cash flow | -13.40%-5.83M | 29.57%-5.27M | -13.96%-6.28M | 30.73%-26.52M | 32.56%-8.38M | 45.23%-5.14M | -8.46%-7.48M | 42.41%-5.51M | -63.29%-38.28M | -113.26%-12.43M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data